多功能自愈和响应pH的水凝敷料,基于酸和氨酸,用于按需释放药物
Yan Wang1, Chufan Yang1, Weigang Zhang2
1State Key Laboratory of Advanced Technology for Materials Synthesis and Processing, Wuhan University of Technology, Wuhan 430070, China; Sanya Science and Education Innovation Park of Wuhan University of Technology, Sanya 572000, China.
International journal of biological macromolecules
|January 26, 2025
概括
这项研究开发了一种含有和酸的响应pH的水凝伤口敷料. 这种智能包裹有效地对抗细菌感染,促进受感染的伤口愈合.
科学领域:
- 生物材料科学 生物材料科学
- 伤口治愈研究研究 伤口治愈研究
- 药物输送系统 药物输送系统
背景情况:
- 细菌感染和炎症阻碍受感染的伤口愈合.
- 聚糖化水凝为伤口包装应用提供了潜在的潜力.
- 需要先进的伤口带,可控制治疗剂的释放.
研究的目的:
- 开发一种适应pH的水凝伤口敷料 (FA/β-CD@CG-HA-Zn) 用于感染的伤口.
- 调查水凝的特性,包括自我愈合,药物释放动力学和抗菌活性.
- 评估水凝在促进受感染伤口愈合方面的有效性.
主要方法:
- 制造一个响应pH的水凝,使用酸 guar (CG) 和酸 (HA).
- 加入离子 (Zn2+) 和铁酸/β-环极含有复合物 (FA/β-CD).
- 评估水凝结构,pH触发的FA和Zn2+释放,抗菌功效,以及体内伤口愈合性能.
主要成果:
- 该FA/β-CD@CG-HA-Zn水凝表现出自我愈合特性,并且符合不规则的伤口形状.
- 在pH 7.5与pH 5.5相比,观察到FA和Zn2+的释放速度更快,表明pH响应性.
- 水凝显示出对S. aureus,MRSA和E. coli的显著抗菌活性.
- 在体内研究表明,水凝通过调节免疫微环境和增强血管化来促进伤口愈合.
结论:
- 开发的FA/β-CD@CG-HA-Zn水凝是一种有前途的自我愈合伤口包裹.
- 它的pH触发药物释放能力允许智能和按需的治疗交付.
- 水凝有效地解决了细菌挑战,并加速了受感染的伤口愈合.
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
137
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137
01:23Modified-Release Drug Delivery Systems: Classification
315
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
315
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
172
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
172
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
01:26Oral Drug Delivery Systems: Continuous-Release Systems
308
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
308
01:11Oral Drug Delivery Systems: Delayed-Release Systems
222
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
222